NGS Thyroid Carcinoma

Mutation Hotspot: AKT1, BRAF, CTNNB1, HRAS, KRAS, NRAS, PIK3CA, RET, TERT; Fusions: RET, PPARG, NTRK1, NTRK2, NTRK3 and Pathogenic Changes Oncomine Comprehensive Assays v3 DNA. To order this analysis, please contact us via contact@viollier.ch or 0848 121 121. This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG shall arrange for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). Tarification: according to Tarmed.